Cardiol Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDL and other ETFs, options, and stocks.About CRDL
Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases.
CEODavid G. Elsley
CEODavid G. Elsley
Employees22
Employees22
HeadquartersOakville, Ontario
HeadquartersOakville, Ontario
Founded2017
Founded2017
Employees22
Employees22
CRDL Key Statistics
Market cap99.66M
Market cap99.66M
Price-Earnings ratio-3.18
Price-Earnings ratio-3.18
Dividend yield—
Dividend yield—
Average volume312.29K
Average volume312.29K
High today$1.01
High today$1.01
Low today$0.955
Low today$0.955
Open price$0.96
Open price$0.96
Volume169.75K
Volume169.75K
52 Week high$1.59
52 Week high$1.59
52 Week low$0.7709
52 Week low$0.7709
Stock Snapshot
The current Cardiol Therapeutics(CRDL) stock price is $1.01, with a market capitalization of 99.66M. The stock trades at a price-to-earnings (P/E) ratio of -3.18.
As of 2026-01-02, Cardiol Therapeutics(CRDL) stock has fluctuated between $0.96 and $1.01. The current price stands at $1.01, placing the stock +5.8% above today's low and 0.0% off the high.
The Cardiol Therapeutics(CRDL)'s current trading volume is 169.75K, compared to an average daily volume of 312.29K.
During the past year, Cardiol Therapeutics(CRDL) stock moved between $0.77 at its lowest and $1.59 at its peak.
During the past year, Cardiol Therapeutics(CRDL) stock moved between $0.77 at its lowest and $1.59 at its peak.
People also own
Based on the portfolios of people who own CRDL. This list is generated using Robinhood data, and it’s not a recommendation.